USPTO serial 79339892
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Smith
Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.2200 Clarendon BoulevardSuite 1400Arlington, VA 22201| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research in the field of immunotherapy; designing a scientific method for desensitization via epicutaneous immunotherapy applied to clean and dry skin, without the skin being pre-prepared that leaves the cell structure of epidermis intact; scientific research in the field of allergy treatments and therapies; scientific research relating to allergy treatments that are repeatedly applied to the clean and dry skin without the skin being pre-prepared that leaves the cellular structure of the epidermis intact, to allow allergen to be presented to the skin immune cell whilst limiting allergen entering from getting into the bloodstream; medical research services, namely, discovery and development of allergens; designing medical treatment methods for allergies by associating allergens to immune cells present in the skin; designing medical treatment methods for allergies consisting of the application of a patch on the intact clean and dry skin of the patient without the skin being pre-prepared that leaves the cellular structure of the epidermis intact | SECTION 70 - CANCELLED | — |
| 044 | Medical services consisting of the application of a desensitization method using immunotherapy; medical treatments of allergies comprising the administration of allergens by putting a patch on the intact skin of a patient to prevent the allergen from getting into the blood; medical treatments of allergies using desensitization via epicutaneous immunotherapy; epicutaneous medical treatments of allergies applied to clean and dry skin without the skin being pre-prepared that leaves the cellular structure of the epidermis intact; medical consulting in the field of desensitizing against allergies | SECTION 70 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 27, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 27, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 17, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 20, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 2, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 29, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 13, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 31, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 11, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 11, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 12, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 14, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 14, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 21, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 20, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 17, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 10, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 6, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 5, 2022 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |